Clinical correlates, prognostic impact and survival outcomes in chronic myelomonocytic leukemia patients with the JAK2V617F mutation

• Mrinal M. Patnaik,
• Prateek A. Pophali,
• Terra L. Lasho,
• Christy M. Finke,
• Pedro Horna,
• Rhett P. Ketterling,
• Naseema Gangat,
• Abhishek A. Mangaonkar,
• Animesh Pardanani,
• Ayalew Tefferi

Affiliations

Mrinal M. Patnaik

Division of Hematology, Department of Medicine

Prateek A. Pophali

Division of Hematology, Department of Medicine

Terra L. Lasho

Division of Hematology, Department of Medicine

Christy M. Finke

Division of Hematology, Department of Medicine

Pedro Horna

Division of Hematopathology, Department of Laboratory Medicine and Pathology

Rhett P. Ketterling

Division of Cytogenetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA

Naseema Gangat

Division of Hematology, Department of Medicine

Abhishek A. Mangaonkar

Division of Hematology, Department of Medicine

Animesh Pardanani

Division of Hematology, Department of Medicine

Ayalew Tefferi

Division of Hematology, Department of Medicine